June 30, 2026
Healthcare Prognosis 2026: Experts see rising trust in AI, a commoditizing GLP-1 market, a stalled IPO outlook, and disruptive frontier models.
June 23, 2026
Mitzera CEO Whit Bernard on building a differentiated obesity biotech, navigating a pharma bidding war, and the future of weight-loss drugs.
June 2, 2026
Cogent CEO Andy Robbins on building a breakthrough biotech: trusting scientific conviction over market fear and why targeted therapies are underrated.
May 6, 2026
SmithRx CEO Jake Friends on building a transparent PBM to fix the broken drug pricing black box, saving employers 20% or more.
April 9, 2026
Author Brad Stulberg redefines excellence as a process, not a result. He discusses focusing on the pursuit, embracing curiosity, and finding joy.
April 1, 2026
AI expert Melanie Mitchell discusses the gap between narrow AI and true understanding, why benchmarks fail, and the need for explainable systems.
March 18, 2026
Dr. Bob Wachter discusses AI's inflection point in healthcare, from a tool augmenting doctors to a force reshaping the entire system.
February 25, 2026
Astronomer CEO Pete DeJoy on building the leading data orchestration platform, the evolution of data engineers with AI, and lessons in crisis management.
February 19, 2026
Experts reveal why U.S. blood pressure control has failed to improve: it's a systems problem, not a clinical one, solvable by new incentives.
February 11, 2026
Inrix CEO Brian Mestelli shares the blueprint for their company-wide “Innovation Week” hackathon, a key driver for innovation and morale.
February 5, 2026
Navy CTO Justin Fanelli discusses building AI trust through evidence, outcome-based contracts, and fostering a merit-based defense ecosystem.
January 28, 2026
Dr. Zeke Emanuel shares 6 simple rules for a longer, healthier life, emphasizing social connection, cognitive engagement, and diet over fads.
January 21, 2026
Forterra's leaders share their playbook for building a warfighter-first autonomy company, detailing product focus, fundraising, and go-to-market.
January 8, 2026
Tubulus CEO Dominic Schumacher on building next-gen cancer therapies (ADCs) with novel chemistry and leading with a data-driven, trust-based culture.
December 9, 2025
Venrock's 2026 healthcare predictions: AI wars loom despite new billing codes, drug costs rise, and Medicare Advantage faces turmoil.
November 12, 2025
Rhythm Pharma CFO Hunter Smith on navigating biotech volatility, strategic financing, and turning a single-digit stock into a $100+ success.
November 5, 2025
New Mountain Capital's Matt Holt discusses fixing US healthcare by tackling its $500B administrative bloat with AI to build a patient-centric system.
October 15, 2025
CRISPR CEO Sam Kulkarni on building a revolutionary biotech, navigating market cycles, and the future of gene editing as molecular surgery.
